Sexual Health & Medical Wellness Johns Hopkins Researchers Develop Novel Intranasal DNA Vaccine to Combat Drug-Tolerant Tuberculosis Persisters September 28, 2026 Susilo Ahmad Tuberculosis remains a formidable global health crisis, persisting as one of the deadliest infectious diseases in human history despite six millennia of coexistence with our species. A team of researchers…
Sexual Health & Medical Wellness Breakthrough Intranasal DNA Vaccine Offers New Hope for Eradicating Drug-Tolerant Tuberculosis Persisters September 12, 2026 Susilo Ahmad Researchers at Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health have unveiled a pioneering experimental therapeutic DNA vaccine that could fundamentally shift the paradigm of tuberculosis…